Rebound Syndrome in Multiple Sclerosis After Fingolimod Cessation.
Department of Psychopharmacology, National Institute of Mental Health and Neurosciences, Bangalore, India.
Chittaranjan
C
Andrade
D000068876:Fingolimod Hydrochloride; D006801:Humans; D007166:Immunosuppressive Agents; D009103:Multiple Sclerosis; D020529:Multiple Sclerosis, Relapsing-Remitting
D007166:Immunosuppressive Agents; D000068876:Fingolimod Hydrochloride